Abstract | OBJECTIVE: METHODS: We performed a literature search in MEDLINE, Embase, and Cochrane Library for randomized controlled trials (RCTs) and observational studies. Proportion of patients with complete venous ulcer healing was the primary outcome and lower leg volume, foot volume, ankle circumference and symptoms were the secondary outcomes. Bayesian network meta-analysis (NMA) was perfomed with random effects models using only RCTs. A meta-analysis of observational studies was performed for sulodexide because no RCT could be included in NMA for symptoms or signs. RESULTS: Forty-five RCTs and eighteen observational studies were identified. Sulodexide was included only in a single NMA for the proportion of patients with complete ulcer healing and it showed to have the highest probability of being the best treatment (48%) compared with pentoxifylline (37%) and MPFF (16%). MPFF was the most effective treatment in reducing lower leg volume, CIVIQ-20 score and pain VAS scale while calcium dobesilate and Ruscus+HMC+VitC were the most effective in reducing foot volume and ankle circumference respectively.Meta-analyses of observational studies for sulodexide showed that it improves significantly the scoring of pain, feeling of swelling, heaviness and parasthesiae measured by Likert scales. CONCLUSIONS:
Sulodexide is at least as effective as pentoxifylline and more effective than MPFF in improving the rate of ulcer healing in patients with CVD. VADs are effective in improving venous symptoms and signs, as was also shown by sulodexide in the meta-analysis of observational studies. The relative effectiveness of sulodexide and VADs needs to be evaluated by an RCT in order to better inform clinical practice.
|
Authors | Giuseppe Pompilio, Andrew Nicolaides, Stavros K Kakkos, Davide Integlia |
Journal | Phlebology
(Phlebology)
Vol. 36
Issue 9
Pg. 695-709
(Oct 2021)
ISSN: 1758-1125 [Electronic] England |
PMID | 33983078
(Publication Type: Journal Article, Meta-Analysis, Systematic Review)
|
Chemical References |
- Glycosaminoglycans
- Pharmaceutical Preparations
- glucuronyl glucosamine glycan sulfate
|
Topics |
- Glycosaminoglycans
- Humans
- Network Meta-Analysis
- Pharmaceutical Preparations
- Varicose Ulcer
(drug therapy)
- Vascular Diseases
|